Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review  S.J.L. Flatters, P.M. Dougherty, L.A.

Similar presentations


Presentation on theme: "Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review  S.J.L. Flatters, P.M. Dougherty, L.A."— Presentation transcript:

1 Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review  S.J.L. Flatters, P.M. Dougherty, L.A. Colvin  British Journal of Anaesthesia  Volume 119, Issue 4, Pages (October 2017) DOI: /bja/aex229 Copyright © 2017 The Author(s) Terms and Conditions

2 Fig 1 Summary of the pathophysiological events contributing to chemotherapy-induced peripheral neuropathy (CIPN) as highlighted in this review. The most common agents provoking CIPN are shown in the bubble in A and the sites of action for these compounds are indicated by the arrows. The structures are also labeled in A while in B the changes occurring in these structures with CIPN are summarized. Reproduced with permission from Boyette-Davis JA, Walters ET, Dougherty PM, Mechanisms involved in the development of chemotherapy induced peripheral neuropathy. Pain Manag. 5 (4): , 2015. British Journal of Anaesthesia  , DOI: ( /bja/aex229) Copyright © 2017 The Author(s) Terms and Conditions


Download ppt "Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review  S.J.L. Flatters, P.M. Dougherty, L.A."

Similar presentations


Ads by Google